From Scale to Innovation

Executive Summary

Emerging markets (EMs) have historically been associated with commodity exports and low-cost manufacturing. Those characteristics remain relevant in parts of the investable universe, but the sources of competitive advantage have broadened materially.

Today, a growing number of EM companies compete through technology leadership, advanced manufacturing, scientific know-how and business-model innovation, alongside more traditional strengths in scale, resources and cost. These capabilities allow EM companies to build internationally relevant franchises and, in some cases, shape the industries in which they operate.

For investors, this broadens the opportunity set beyond traditional EM exposures, creating access to companies with globally relevant capabilities and competitive advantages.

Technology Expertise: A Visible EM Advantage

Several of the largest companies in EMs occupy strategically important positions in the global technology supply chain. Their competitive strength increasingly reflects technological complexity, intellectual property, manufacturing know-how and strategic positioning. These companies do not compete based on manufacturing scale alone.

Much of the hardware underpinning artificial intelligence is produced by companies based in EMs. Asian businesses play central roles across the semiconductor value chain, including data-centre infrastructure, memory, connectivity, advanced packaging and third-party foundry services.

EM firms now account for nearly 90% of the global pure-play semiconductor foundry market, highlighting how some of the world’s most valuable technologies depend on capabilities developed in EMs.¹ The leadership also extends to memory, particularly high-bandwidth memory. In the second quarter of 2026, South Korean companies accounted for more than 80% of this market.²

This evolution is not confined to the digital economy. Across industries, EM companies are increasingly influencing some of the world’s most important structural trends.

See more: The Mega-cap IPOs’ Impact on Index Funds

Powering the Electrification Revolution

These trends include electrification, as the global demand for power continues to rise. This has created a surge in demand for related infrastructure, including electric vehicles and energy storage batteries. Founded as a rechargeable-battery manufacturer, one Chinese automaker entered the automotive market in 2003 and has since built deep capabilities across battery chemistry, power electronics and vehicle manufacturing. In 2025, it sold 4.6 million new-energy vehicles globally, including more than one million units overseas.³

The company’s vertically integrated model gives it greater control over key components, including batteries, electric motors and electronic controls. This can support faster product development cycles, closer coordination of system design and a greater ability to capture value across the supply chain.

The company has developed into a major global participant in electric vehicles, batteries and energy-storage systems. Its progress illustrates how EM businesses can increasingly export the technologies that support broad industrial change—in this case, the transition towards electrification.

Enabling Biologics Innovation

The shift towards more complex biologic medicines and higher outsourcing has increased the importance of specialised partners that can support drug development, clinical manufacturing and commercial-scale production. A China-based biologics contract research, development and manufacturing organisation (CRDMO) has built an integrated platform spanning these activities, supporting customers from early-stage development through commercialisation.

Today, the company is a leading biologics CRDMO with over 1,000 integrated projects.⁴ The company supports a broad and increasingly complex mix of modalities through proprietary technology platforms and processes and scaled digital capabilities that aim to shorten development timelines, improve productivity and lower manufacturing costs.

The company’s development reflects a broader evolution: EM firms are increasingly creating value through scientific expertise, technological capability and operational execution, rather than manufacturing scale alone.

Exporting a Shared-Value Insurance Model

Innovation in EMs is not limited to physical products or industrial technology. A leading South African financial services group has developed a “shared-value” approach through its science-based behaviour-change platform, which seeks to align incentives between insurers and customers by rewarding healthier behaviour.

The model has expanded internationally through partnerships with insurers across multiple markets. The company is also applying related principles in banking, linking certain customer behaviours with financial rewards.

This example highlights another route to global relevance: the export of a repeatable business model. When supported by data, customer engagement and distribution partnerships, such models can create durable advantages that are difficult to replicate quickly. The global reach of this “shared-value” approach is showcased in the picture below.

Conclusion: The New Geography of Corporate Leadership

These examples point to a broader evolution in the geography of corporate leadership. EM companies are increasingly competing through capabilities that can be difficult to replicate, including technological expertise, specialised manufacturing, scientific know-how, scale, data and network effects.

For investors, the implication is important. Businesses that convert these capabilities into durable competitive advantages may be able to sustain attractive returns on capital and retain pricing power over time. The new generation of EM leaders therefore look very different from those of the past: not merely beneficiaries of global structural trends, but companies increasingly helping to build and enable them.

Endnotes

Counterpoint Research, as of 30 June 2026.
Counterpoint Research, as of 30 June 2026.
The Business Times, published 1 January 2026.
As at end of June 2026.

WHAT ARE THE RISKS?

All investments involve risks, including possible loss of principal.

Equity securities are subject to price fluctuation and possible loss of principal.

To the extent a portfolio invests in a concentration of certain securities, regions or industries, it is subject to increased volatility.

Large-capitalization companies may fall out of favor with investors based on market and economic conditions. Small- and mid-cap stocks involve greater risks and volatility than large-cap stocks.

International investments are subject to special risks, including currency fluctuations and social, economic and political uncertainties, which could increase volatility. These risks are magnified in emerging markets.

The government’s participation in the economy is still high and, therefore, investments in China will be subject to larger regulatory risk levels compared to many other countries.

There are special risks associated with investments in China, Hong Kong and Taiwan, including less liquidity, expropriation, confiscatory taxation, international trade tensions, nationalization and exchange control regulations and rapid inflation, all of which can negatively impact the fund. Investments in Hong Kong and Taiwan could be adversely affected by its political and economic relationship with China.

Any companies and/or case studies referenced herein are used solely for illustrative purposes; any investment may or may not be currently held by any portfolio advised by Franklin Templeton. The information provided is not a recommendation or individual investment advice for any particular security, strategy or investment product and is not an indication of the trading intent of any Franklin Templeton managed portfolio.

Important Information

This material is intended to be of general interest only and should not be construed as individual investment advice or a recommendation or solicitation to buy, sell or hold any security or to adopt any investment strategy. It does not constitute legal or tax advice. This material may not be reproduced, distributed or published without prior written permission from Franklin Templeton.

The views expressed are those of the investment manager and the comments, opinions and analyses are rendered as at publication date and may change without notice. The underlying assumptions and these views are subject to change based on market and other conditions and may differ from other portfolio managers or of the firm as a whole. The information provided in this material is not intended as a complete analysis of every material fact regarding any country, region or market. There is no assurance that any prediction, projection or forecast on the economy, stock market, bond market or the economic trends of the markets will be realized. The value of investments and the income from them can go down as well as up and you may not get back the full amount that you invested. Past performance is not necessarily indicative nor a guarantee of future performance. All investments involve risks, including possible loss of principal.

Any research and analysis contained in this material has been procured by Franklin Templeton for its own purposes and may be acted upon in that connection and, as such, is provided to you incidentally. Data from third party sources may have been used in the preparation of this material and Franklin Templeton ("FT") has not independently verified, validated or audited such data. Although information has been obtained from sources that Franklin Templeton believes to be reliable, no guarantee can be given as to its accuracy and such information may be incomplete or condensed and may be subject to change at any time without notice. The mention of any individual securities should neither constitute nor be construed as a recommendation to purchase, hold or sell any securities, and the information provided regarding such individual securities (if any) is not a sufficient basis upon which to make an investment decision. FT accepts no liability whatsoever for any loss arising from use of this information and reliance upon the comments, opinions and analyses in the material is at the sole discretion of the user.

Franklin Templeton has environmental, social and governance (ESG) capabilities; however, not all strategies or products for a strategy consider “ESG” as part of their investment process.

Products, services and information may not be available in all jurisdictions and are offered outside the U.S. by other FT affiliates and/or their distributors as local laws and regulation permits. Please consult your own financial professional or Franklin Templeton institutional contact for further information on availability of products and services in your jurisdiction.

Issued in the U.S. by Franklin Templeton, One Franklin Parkway, San Mateo, California 94403-1906, (800) DIAL BEN/342-5236, franklintempleton.com. Investments are not FDIC insured; may lose value; and are not bank guaranteed.

You need Adobe Acrobat Reader to view and print PDF documents. Download a free version from Adobe's website.

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.

A message from Advisor Perspectives and VettaFi: Discover something new! Click here to register for our upcoming webcasts.